The introduction of ultra high-cost drugs, such as gene and cell therapies, is set to reshape pharmacy practices, according to a forecast published in the American Journal of Health-System Pharmacy from the American Society of Health-System Pharmacists and ASHP Foundation, its philanthropic arm.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
